Alnylam Pharmaceuticals · 16 hours ago
Director, Financial Planning & Analysis
Cambridge, MA
Full-time
Hybrid
Director/Executive
$196K/yr - $264K/yr
10+ years expAlnylam Pharmaceuticals is seeking a Director of Business Development FP&A to serve as a senior, finance-focused partner within the Business Development Finance organization. This role involves leading financial evaluations, providing analytical support for strategic decisions, and managing a finance professional to enhance analytical rigor within the Finance organization.
BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics
Responsibilities
Lead and execute financial evaluations in support of the Business Development organization, including valuation modeling, scenario and sensitivity analyses, and comparable transaction benchmarking
Deliver hands-on financial analyses for potential and existing alliances and partnerships to support strategic reviews, business cases, and long-range planning
Oversee, review, and coach one direct report, ensuring high-quality financial models, sound assumptions, and consistent analytical standards
Serve on deal teams, providing valuation, diligence, and analytical support throughout the transaction lifecycle while maintaining independent financial judgment
Review term sheets and contracts, advising on financial aspects and key provisions, and coordinate input from Accounting, Tax, Treasury, and other finance functions to ensure a comprehensive and consistent financial perspective
Partner with senior leaders across R&D, Technical Operations, and Commercial to translate complex business questions into financial frameworks and decision-ready analyses
Lead and execute finance-led strategic analyses for the Executive Leadership Team (ELT), delivering clear, data-driven insights to support enterprise strategic and operational decisions
Synthesize analyses into actionable, finance-grounded recommendations that inform strategic planning, capital allocation, and operational improvement initiatives
Directly manage and develop one finance professional, providing coaching, technical guidance, and performance feedback
Contribute to the development and continuous improvement of tools, templates, and best practices that elevate analytical rigor and consistency across the Finance organization
Qualification
Required
Bachelor's Degree in Finance or other degrees with quantitative focus (e.g. Statistics, Economics, Mathematics) required
A minimum of 10+ years of progressive experience in Finance within biotech, pharma, or life sciences
Strong business acumen with experience supporting R&D, portfolio, or business development functions
Strong understanding of financial models, valuations, and business proposals
Ability to manage multiple priorities and deliver high-quality work under tight timelines
Demonstrated ability to influence and communicate effectively with senior stakeholders in a matrixed environment
Demonstrated ability to translate complex financial information and assumptions into effective presentations
Advanced financial modeling and valuation skills — ability to build and interpret discounted cash flow (DCF), NPV, IRR, and scenario-based models for BD and strategic decisions
Strong intellectual curiosity and initiative – proactively identifying opportunities for optimization or insight generation
Strong collaboration skills, with an ability to inspire and motivate teams
Excellent analytical, strategic planning, and problem-solving skills
Thrives in a fast-paced, matrixed environment where priorities shift and collaboration is key
Attention to detail and high standards of analytical accuracy under tight timelines
Ability to influence and build relationships at all levels of the organization
Preferred
MBA, CFA, or equivalent strongly preferred
Benefits
Comprehensive benefits including medical, dental, and vision coverage
Life and disability insurance
Lifestyle reimbursement program
Flexible spending and health savings accounts
401(k) with a generous company match
Paid time off
Wellness days
Holidays
Two company-wide recharge breaks
Generous family resources and leave
Company
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
1001-5000 employees
Funding
Current Stage
Public CompanyTotal Funding
$4.55BKey Investors
Blackstone Life SciencesBlackstone CreditRegeneron
2025-09-09Post Ipo Debt· $661.25M
2022-09-12Post Ipo Debt· $900M
2022-03-04IPO
Leadership Team
Yvonne Greenstreet
Chief Executive Officer
Jeff Poulton
Chief Financial Officer
Recent News
Clinical Trials Arena
2026-01-16
Longevity.Technology
2026-01-14
2026-01-13
Company data provided by crunchbase